Avidity Biosciences, Inc. reported unaudited financial results for the first quarter ended March 31, 2021. For the quarter, Collaboration revenue was $2,704,000 against $1,358,000 a year ago. Loss from operations was $23,857,000 against $6,150,000 a year ago. Net loss was $23,844,000 or $0.64 per basic share against $6,085,000 or $2.14 per basic share a year ago.